• HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Friday, May 20, 2022
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
    • BIOENGINEERING
    • SCIENCE NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • FORUM
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Regular blueberry consumption may reduce risk of dementia, study finds

Bioengineer by Bioengineer
May 11, 2022
in Science News
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The old adage says that an apple a day keeps the doctor away, but new research from the University of Cincinnati shows the potential benefit of a different fruit for your health. 

Robert Krikorian

Credit: Photo/University of Cincinnati

The old adage says that an apple a day keeps the doctor away, but new research from the University of Cincinnati shows the potential benefit of a different fruit for your health. 

Researchers led by UC’s Robert Krikorian, PhD, found that adding blueberries to the daily diets of certain middle-aged populations may lower the chances of developing late-life dementia. The findings were recently published in the journal Nutrients. 

Research approach 

Krikorian said his team has been conducting research on the benefits of berries for people with greater risk for Alzheimer’s disease and dementia for several years. 

While not entirely different from other berries and plants like red cabbage, Krikorian said blueberries have a particularly high level of micronutrients and antioxidants called anthocyanins. Anthocyanins help give blueberries their namesake color and also help defend the plants against excess radiation exposure, infectious agents and other threats, Krikorian said. 

These same properties that help blueberries survive also provide benefits to humans, Krikorian said, such as reducing inflammation, improving metabolic function and enhancing energy production within cells. 

Previous berry studies Krikorian led focused on older populations, but with this research, the team wanted to study middle-aged individuals in order to focus on dementia prevention and risk reduction. 

Krikorian explained that about 50% of individuals in the U.S. develop insulin resistance, commonly referred to as prediabetes, around middle age. Prediabetes has been shown to be a factor in chronic diseases, he said.  

“We had observed cognitive benefits with blueberries in prior studies with older adults and thought they might be effective in younger individuals with insulin resistance,” said Krikorian, professor emeritus and director of the division of psychology in the UC College of Medicine’s Department of Psychiatry and Behavioral Neuroscience. “Alzheimer’s disease, like all chronic diseases of aging, develops over a period of many years beginning in midlife.” 

Study details and results 

The researchers enrolled 33 patients from around the Cincinnati area between the ages of 50-65 who were overweight, prediabetic and had noticed mild memory decline with aging. Krikorian said this population has an increased risk for late-life dementia and other common conditions. 

Over a period of 12 weeks, the patients were asked to abstain from berry fruit consumption of any kind except for a daily packet of supplement powder to be mixed with water and consumed either with breakfast or dinner. Half of the participants received powders that contained the equivalent of one-half cup of whole blueberries, while the other half received a placebo. 

Participants were also given tests that measured certain cognitive abilities that decline in patients with aging and late-life dementia, such as executive functions like working memory, mental flexibility and self control. 

Krikorian said those in the blueberry-treated group showed improvement on cognitive tasks that depend on executive control.  

“This was evident as reduced interference of extraneous information during learning and memory,” Krikorian explained. 

Patients in the blueberry group also had lower fasting insulin levels, meaning the participants had improved metabolic function and were able to more easily burn fat for energy.  

Krikorian said the blueberry group displayed an additional mild degree of higher mitochondrial uncoupling, a cellular process that has been associated with greater longevity and reduced oxidative stress. Oxidative stress can lead to symptoms like fatigue and memory loss. 

“This last finding was exploratory but points to an interesting, potential mechanism for blueberry benefits,” he said. 

Moving forward, Krikorian said he is interested in better understanding the exact mechanisms of blueberries that help to improve cognitive performance and metabolic function. But the main takeaway from the current study is that regular blueberry supplementation into at-risk middle-aged diets may lower the chances of developing late-life dementia. 

“The sample size is an obvious limitation of the study, so it will be important to reproduce these findings, especially by other investigators,” Krikorian said. “In the meantime, it might be a good idea to consume blueberries on a regular basis.”   

This research was funded by the U.S. Highbush Blueberry Council of Folsom, California. This organization also provided the blueberry powder and placebo powder research products. The research authors declare no conflict of interest. The funding organization had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript or in the decision to publish the results.



Journal

Nutrients

DOI

10.3390/nu14081619

Method of Research

Randomized controlled/clinical trial

Subject of Research

People

Article Title

Blueberry Supplementation in Midlife for Dementia Risk Reduction

Article Publication Date

15-Mar-2022

COI Statement

This research was funded by the U.S. Highbush Blueberry Council of Folsom, California. This organization also provided the blueberry powder and placebo powder research products. The research authors declare no conflict of interest. The funding organization had no role in the design of the study; in the collection, analyses or interpretation of data; in the writing of the manuscript or in the decision to publish the results.

Share12Tweet7Share2ShareShareShare1

Related Posts

6° Convegno di Fondazione Arianna e Anticoagulazione.it

Venous thromboembolism: Less recurrencies with low-dose apixaban compared to discontinuation of the anticoagulant after negative D-dimer

May 20, 2022
Insomnia

Insomnia in midlife may manifest as cognitive problems in retirement age

May 20, 2022

Engineers evaluate the factors behind battery performance at low temperatures

May 20, 2022

Learning more about bird diversity: What a museum collection in Romania can tell us

May 20, 2022

POPULAR NEWS

  • Weybourne Atmospheric Observatory

    Breakthrough in estimating fossil fuel CO2 emissions

    46 shares
    Share 18 Tweet 12
  • Hidden benefit: Facemasks may reduce severity of COVID-19 and pressure on health systems, researchers find

    44 shares
    Share 18 Tweet 11
  • Discovery of the one-way superconductor, thought to be impossible

    43 shares
    Share 17 Tweet 11
  • Sweet discovery could drive down inflammation, cancers and viruses

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Tags

VaccineUrbanizationZoology/Veterinary ScienceVirusVaccinesUniversity of WashingtonWeaponryVirologyUrogenital SystemViolence/CriminalsVehiclesWeather/Storms

Recent Posts

  • Venous thromboembolism: Less recurrencies with low-dose apixaban compared to discontinuation of the anticoagulant after negative D-dimer
  • Insomnia in midlife may manifest as cognitive problems in retirement age
  • Engineers evaluate the factors behind battery performance at low temperatures
  • Learning more about bird diversity: What a museum collection in Romania can tell us
  • Contact Us

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....